217 related articles for article (PubMed ID: 19172025)
21. Final report on the amended safety assessment of sodium polynaphthalenesulfonate and sodium naphthalenesulfonate.
Cosmetic Ingredients Review Expert Panel
Int J Toxicol; 2003; 22 Suppl 2():37-44. PubMed ID: 14555418
[TBL] [Abstract][Full Text] [Related]
22. Patch tests versus use tests in skin irritation risk assessment.
Basketter D; Gilpin G; Kuhn M; Lawrence D; Reynolds F; Whittle E
Contact Dermatitis; 1998 Nov; 39(5):252-6. PubMed ID: 9840263
[TBL] [Abstract][Full Text] [Related]
23. Patch testing with patients' own cosmetics and toiletries--results of the IVDK*, 1998-2002.
Uter W; Balzer C; Geier J; Frosch PJ; Schnuch A
Contact Dermatitis; 2005 Oct; 53(4):226-33. PubMed ID: 16191021
[TBL] [Abstract][Full Text] [Related]
24. Topical botanically derived products: use, skin reactions, and usefulness of patch tests. A multicentre Italian study.
Corazza M; Borghi A; Gallo R; Schena D; Pigatto P; Lauriola MM; Guarneri F; Stingeni L; Vincenzi C; Foti C; Virgili A
Contact Dermatitis; 2014 Feb; 70(2):90-7. PubMed ID: 23909860
[TBL] [Abstract][Full Text] [Related]
25. Allergic contact dermatitis and cosmetics.
Watkins S; Zippin J
Cutis; 2012 Oct; 90(4):201-4. PubMed ID: 23259208
[TBL] [Abstract][Full Text] [Related]
26. Final report on the safety assessment of Malic Acid and Sodium Malate.
Fiume Z
Int J Toxicol; 2001; 20 Suppl 1():47-55. PubMed ID: 11358110
[TBL] [Abstract][Full Text] [Related]
27. Allergic contact dermatitis to cosmetics.
Park ME; Zippin JH
Dermatol Clin; 2014 Jan; 32(1):1-11. PubMed ID: 24267417
[TBL] [Abstract][Full Text] [Related]
28. Contact dermatitis associated with a cosmetic cream.
Jiang Y; Wang S; Lyu J; Li J; Diao Q
J Cosmet Dermatol; 2022 Oct; 21(10):4479-4481. PubMed ID: 35156746
[TBL] [Abstract][Full Text] [Related]
29. Allergy to cosmetics: a literature review.
Alani JI; Davis MD; Yiannias JA
Dermatitis; 2013; 24(6):283-90. PubMed ID: 24201464
[TBL] [Abstract][Full Text] [Related]
30. Patch testing in patients with suspected cosmetic dermatitis: A retrospective study.
Garg T; Agarwal S; Chander R; Singh A; Yadav P
J Cosmet Dermatol; 2018 Feb; 17(1):95-100. PubMed ID: 28568892
[TBL] [Abstract][Full Text] [Related]
31. Cosmetics as causes of allergic contact dermatitis.
Dooms-Goossens A
Cutis; 1993 Nov; 52(5):316-20. PubMed ID: 8299396
[TBL] [Abstract][Full Text] [Related]
32. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
33. Final report on the amended safety assessment of Propyl Gallate.
Int J Toxicol; 2007; 26 Suppl 3():89-118. PubMed ID: 18080874
[TBL] [Abstract][Full Text] [Related]
34. The role of contact allergy in the spectrum of adverse effects caused by cosmetics and toiletries.
de Groot AC; Beverdam EG; Ayong CT; Coenraads PJ; Nater JP
Contact Dermatitis; 1988 Sep; 19(3):195-201. PubMed ID: 3191681
[TBL] [Abstract][Full Text] [Related]
35. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
36. Final amended report on the safety assessment of Octyldodecyl Stearoyl Stearate.
Int J Toxicol; 2005; 24 Suppl 3():65-74. PubMed ID: 16422265
[TBL] [Abstract][Full Text] [Related]
37. Amended final report of the safety assessment of dibutyl adipate as used in cosmetics.
Andersen A
Int J Toxicol; 2006; 25 Suppl 1():129-34. PubMed ID: 16835133
[TBL] [Abstract][Full Text] [Related]
38. Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics.
Faller C; Bracher M; Dami N; Roguet R
Toxicol In Vitro; 2002 Oct; 16(5):557-72. PubMed ID: 12206823
[TBL] [Abstract][Full Text] [Related]
39. Final amended report on the safety assessment of oxyquinoline and oxyquinoline sulfate as used in cosmetics.
Andersen A
Int J Toxicol; 2006; 25 Suppl 1():1-9. PubMed ID: 16835127
[TBL] [Abstract][Full Text] [Related]
40. Provocative use tests in CAPB-allergic subjects with CAPB-containing product.
Fartasch M; Diepgen TL; Kuhn M; Basketter DA
Contact Dermatitis; 1999 Jul; 41(1):30-4. PubMed ID: 10416705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
